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Background: Acute thoracic aortic injury resulting from blunt trauma is a life-threatening condition. Endovascular
therapy is a less invasive treatment modality that may potentially improve patient outcomes. We reviewed our experience
with patients who sustained blunt thoracic aortic injuries distal to the left subclavian artery and presented for open
surgical or endovascular repair.
Methods: Between August 1993 and August 2006, 62 patients sustained blunt thoracic aortic injuries distal to the origin
of the left subclavian artery and proceeded to undergo open surgical (n 48, 77%), or endovascular repair (n 14, 23%).
Revised trauma score (RTS), injury severity score (ISS), new injury severity score (NISS), individual associated traumatic
injuries, as well as operative and postoperative outcomes were compared between open surgical and endovascular groups.
Results: Age, gender, race, and mechanism of injury did not differ between open surgical and endovascular groups.
Additionally, RTS, ISS, and NISS values were not significantly different. The proportion of patients with sternal
fractures (14% vs 0%), or unstable spinal fractures (36% vs 10%) was significantly greater in the endovascular group. Of
the patients who received endografts, 93% (n  13) were evaluated by a cardiothoracic surgeon and assessed to be
prohibitive to operative intervention. Endografts utilized included commercially manufactured thoracic endografts (n
6; 43%) and abdominal aortic endograft components (n 8; 57%). Forty-one interposition grafts were placed in the open
surgical group. Renal complications (32% vs 7%), and urinary tract infections (35% vs 7%) approached significance
between surgical and endovascular groups (P .082 and P .077, respectively). Intraoperative mortality for the surgical
and endovascular groups was 23% and 0%, respectively (P  .056). Endovascular repair was associated with significant
reductions in operative time (118 vs 209 minutes), estimated blood loss (77 vs 3180 ml), and intraoperative blood
transfusions (0.9 vs 6.1 units). No endoleaks were detected during a mean follow-up of 9.4 months in the endovascular
group.
Conclusion: Endovascular repair of blunt descending thoracic aortic injuries utilizing thoracic or abdominal endographs
is a technically feasible modality that is at least equivalent to open therapy in the short term and associated with a lower
intraoperative mortality (P  .056). Endovascular therapy has advantages in operative time, operative blood loss, and
intraoperative blood transfusions. ( J Vasc Surg 2007;46:934-40.)Blunt thoracic aortic injury (TAI) is a highly lethal
injury with a mortality rate at the scene of injury of approx-
imately 85%.1,2 Patients who survive the initial trauma and
present to the hospital remain at risk for mortality second-
ary to the aortic injury.3,4 Despite developments in opera-
tive techniques, there still remains considerable operative
mortality and morbidity associated with a surgical ap-
proach.5,6
Elective endovascular (EV) repair of thoracic aortic
lesions is a less invasive intervention that may be superior to
open surgical repair for the treatment of a variety of de-
scending thoracic aortic lesions.7 A less invasive approach
would be preferable for stabilization of the aortic injury in
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934patients with multiple traumatic injuries. Although single
center experience is limited by the rarity of these traumatic
lesions and the relative infancy of applying endograft tech-
nology to the thoracic aorta, recent reports of endovascular
repair of blunt TAIs have been encouraging.8-11
We reviewed our single-institution experience of pa-
tients treated acutely for blunt injuries to the descending
thoracic aorta over a 13-year period. Patient characteristics
and outcomes were compared between patients who re-
ceived endografts, and those who underwent open surgical
reconstruction. Anatomic and physiologic measures of
traumatic injury severity were compared between groups,
and short-term outcomes are reported.
MATERIALS AND METHODS
Institutional Review Board approval was obtained for
the review of all patient records relevant to this study.
For the time period between August 1993 and August
2006, the University of North Carolina (UNC) Hospital’s
discharge database was searched for International Classifi-
cation of Diseases Version 9 (ICD-9) codes 901.0 injury
aorta (thoracic), 902.0 injury aorta (abdominal), 441.01
thoracic dissection, 441.01 thoracoabdominal dissection,
and 441.1 thoracic aneurysm ruptured. Review of nontho-
racic injury ICD-9 codes was necessary due to misclassifi-
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review of electronic and paper records to identify those
whom sustained acute blunt descending TAI. Patients with
abdominal aortic injuries (n  3), thoracic aortic injuries
secondary to penetrating trauma (n  4), and injuries
proximal to the origin left subclavian artery (SCA) (n  1)
were excluded from this analysis. Additionally, this analysis
only includes patients who presented to the operating room
within 14 days of their injury. Patients who died prior to
undergoing an intervention for their TAI were excluded
(n 2), as were nonoperatively managed patients (n 1).
The location of injury was classified as involving the
isthmus (from just distal to the left SCA to the third
intercostals artery), or the lower descending aorta based
upon intraoperative description and/or radiographic eval-
uation. Injury severity score (ISS)12 and new injury severity
score (NISS)13 were obtained from the UNC Hospital’s
Trauma Registry Database. Revised trauma score (RTS)14
was calculated based upon the initial Glasgow Coma Scale
(GCS), systolic blood pressure (SBP), and respiratory rate
(RR).
For patients undergoing EV repair, aortic measure-
ments were obtained on thin cut CT scans of the chest. In
patients who received thoracic endografts, devices were
sized according to the manufacturer’s instructions for use
(IFU). When appropriately configured thoracic endografts
were not available, often due to a lack of smaller thoracic
devices, abdominal aortic endograft components were uti-
lized and oversized by the attending physician to approxi-
mately 10% of the aortic luminal diameter. All thoracic
devices were appropriately oversized and oversizing of ab-
dominal components did not exceed 20%. In general, prox-
imal and distal landing zones 20 mm were obtained
although landing zones 20 mm were deemed acceptable
if an adequate seal and lesion exclusion were achieved at the
time of deployment. EV outcomes are defined as previously
described.15 Follow-up for both EV and open surgical
patients was based on the most recent clinic visit or through
correspondence if the patient was followed at another
institution. Follow-up evaluation for EV patients consisted
of both cross-sectional and plain film imaging performed at
approximately 30 days, 6 months, and annually thereafter.
Data analysis was performed with the use of StatView
(SAS Institute, Cary, NC). Fisher exact test was used to
compare population proportions and two-tailed P values
are reported. Student t test was used for continuous vari-
ables. Comparisons between groups are referred to as being
statistically significant if P .05, otherwise the P value is
provided for interpretation.
A total of 62 patients met criteria for this review during
the 13-year time period. The majority sustained trauma
secondary to a motor vehicle collision (81%). The average
patient age was 40.3 years and the 20 to 29 age group was
the most prevalent (26%) in our series consistent with
previous reports of TAI in the state of North Carolina.16
The majority of patients had injuries located at the isthmus
(92%), consistent with previously reported series.4,17,18When a delay to intervention was necessary, medical ther-
apy with antihypertensives was routinely utilized.
Fourteen (23%) patients underwent EV repair and 48
(77%) underwent open surgical repair owing to the rela-
tively recent application of endografts to this vascular pa-
thology. At out institution, EV repair of thoracic aortic
lesions became routinely available in 2002. Of the 14 EV
cases, 93% occurred in 2003 or later and since 2002,
approximately 50% of all repairs for acute blunt TAI have
been performed endovascularly. Comparisons of EV and
open surgical patients are listed in Table I. Patient age,
gender, and race did not differ significantly between
groups. The proportion of patients 55 years or older was
also not significant (EV 21% vs open 23%; P  1.000).
Chronic comorbidities did not significantly differ between
treatment groups, but these measures may have been un-
der-reported given the acute assessments of many of these
Table I. Patient characteristics: endovascular and open
surgical repair
Value EV Open P
n 14 48
Age (mean) 40.7 40.2 .931
Male 9 (64%) 36 (75%) .502
White 8 (57%) 32 (67%) .539
Transferred 13 (93%) 25 (52%) .006
SBP 90 mm Hg* 6 (50%)† 24 (50%) .764
Etiology
Motor vehicle collision 9 (64%) 41 (85%) .121
Motorcycle collision 2 (14%) 2 (4%)
Pedestrian hit by car 0 (0%) 3 (6%)
Fall 3 (21%) 1 (2%)
Other 0 (0%) 1 (2%)
Location of aortic injury
Isthmus 12 (86%) 45 (94%) .314
Distal descending thoracic aorta 2 (14%) 3 (6%)
Measures of traumatic injury
RTS 6.589 7.024 .291
ISS 38 41 .491
NISS 45 47 .549
Associated traumatic injuries
Head injury‡ 5 (36%) 10 (21%) .296
Lung injury 9 (64%) 37 (77%) .488
Abdomen§ 9 (64%) 25 (52%) .546
Pelvic fracture 7 (50%) 27 (56%) .765
Long bone fracture 4 (29%) 22 (46%) .357
Rib fractures 8 (57%) 31 (65%) .755
Clavicle fracture 3 (21%) 5 (10%) .365
Scapula fracture 0 (0%) 3 (6%) .179
Sternum fracture 2 (14%) 0 (0%) .048
Neurologic deficits 2 (14%) 4 (8%) .610
Unstable C/T/L spine fractures 5 (36%) 5 (10%) .038
EV, endovascular, SBP, systolic blood pressure, RTS, revised trauma score,
ISS, injury severity score, NISS, new injury severity score, C/T/L, cervical,
thoracic, lumbar.
*Systolic blood pressure90 mm Hg on at least one measurement prior to
intervention.
†n  12, pre-transfer vital sign data incomplete on two EV patients.
‡Radiographic evidence of brain trauma on initial head computer tomogra-
phy scan.
§Solid organ, bowel, bladder, or diaphragm injury.patients. Measures of traumatic injury (RTS, ISS, and
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open surgical groups, nor was evidence of preintervention
hypotension (SBP 90 mm Hg). Only the presence of
sternal fractures and unstable spinal fractures were signifi-
cantly higher in the EV group. Thirteen of the 14 EV
patients (93%) were assessed by cardiothoracic surgeons at
the referring institution and/or our facility and deemed to
be nonoperative surgical candidates due to associated trau-
matic injuries. No specific predetermined criteria were uti-
lized to refer patients for either of the two treatment
modalities. One patient in the EV group had undergone
attempted open surgical repair at a referring institution, but
this was aborted due to inability to tolerate single lung
ventilation. A board certified cardiothoracic surgeon was
one of the surgeons of record in 47 of the 48 cases (98%) of
attempted or successful open surgical repair.
Six (43%) EV patients received commercially manufac-
tured thoracic endografts including the Talent Thoracic
(n 2) (Medtronic AVE, Santa Rosa, Calif), and the Gore
TAG (n 4) (W. L. Gore & Associates Inc, Flagstaff, Ariz)
endoprosthesis. The Talent devices were placed as part of a
Food and Drug Administration approved clinical investiga-
tive protocol and the Gore TAG devices were placed as
off-label applications. Eight (57%) patients received ab-
dominal aortic endograft components including Gore Ex-
cluder Aortic Extender cuffs (n  5); (W. L. Gore &
Associates Inc, Flagstaff, Ariz), Zenith AAA iliac leg exten-
sions (n  2); (Cook Inc, Bloomington, Ind), and a Van-
guard Endovascular Aortic Graft Cuff (n  1); (Boston
Scientific, Nantick, Mass). Multiple endograft components
were deployed in one patient who received a thoracic
endograft and six patients who received abdominal aortic
endograft components. Of the patients who received Gore
Extender cuffs, four required three components and one
required four components. Of the patients who received
Zenith iliac leg extensions, one was successfully excluded
with one component for an injury at the isthmus and the
other required three components to treat a distal descend-
ing thoracic aortic injury. The majority of patients under-
went vascular access through a femoral approach (n  13;
93%), although one patient required iliac artery access in
order to treat an aortic isthmus injury with Gore Extender
cuffs due to the limiting length of the delivery system. All
EV patients received systemic heparin intraoperatively at a
dose of 60 to 80 units/Kg. The majority of EV patients
were treated with general anesthesia (n  12; 86%). Pri-
mary technical success was 100%. Four (29%) EV patients
underwent total coverage of their left SCA, and one (7%)
patient had partial coverage.
Forty-one (85%) open surgical patients underwent left
heart bypass performed through pulmonary vein to distal
descending thoracic aorta utilizing a Bio-Medicus centrif-
ugal pump (Bio-Medicus Inc, Eden Prarie, Minn). Twenty-
four (50%) of the open surgical patients received systemic
heparinazation during the procedure. The majority (85%)
had an interposition Dacron graft (Hemashield; Meadox
Medicals, Inc, Oakland, NJ and Boston Scientific, Wayne,
NJ) placed during the procedure, two underwent primaryrepair, and five did not have interposition graft placement
or primary repair completed prior to intraoperative death.
Mean diameter of the interposition grafts placed was 20.3
mm (range 12 to 26 mm). Of these patients, 27% received
interposition grafts 23 mm and 80% received grafts 18
mm in diameter.
RESULTS
Operative outcomes and in-hospital complications of
EV and open surgical patients are presented in Table II.
The time of injury could not be determined for two patients
in the EV group. The same two patients were transferred
back to their referring institution prior to completion of
their inpatient hospital course. Outcomes and complica-
tions were determined from inpatient notes and discharge
summaries but duration of intensive care unit stay could
not be accurately evaluated from these records. Patients in
the EV group underwent intervention at a significantly
greater time from injury mainly related to the time required
for transfer to our tertiary care center. There were no
intraoperative deaths in the EV group and 11 (23%) deaths
in the open surgical group (P  .056). The EV group had
significantly less blood loss, shorter operative time, and
received less intraoperative units of blood. Five (35%) EV
patients received at least one unit of intraoperative alloge-
neic blood, compared with 44 (92%) of open surgical
patients (P  .001). Intraoperative blood salvage was not
utilized in any of the EV patients while it was used in the
majority (75%) of open surgical patients. Of the 37 opera-
tive open surgical survivors, 97% had undergone partial left
heart bypass and the average aortic cross-clamp time for this
subgroup was 59 minutes. The one open operative survivor
who did not undergo left heart bypass underwent primary
repair through the clamp-and-sew technique with a cross
clamp time of 33 minutes. The greater frequency of renal
complications and urinary tract infections in the open sur-
gical group approached significance. There were no cases of
paraplegia or paraparesis in either the open surgical or EV
groups.
No cases of device migration or endoleak were detected
during a mean follow-up of 9.4 months. Four secondary
procedures were performed in three patients. One patient
underwent prophylactic left SCA stent placement following
total coverage of the left SCA by the endograft resulting in
a monophasic left radial pulse and a cool extremity. Due to
inability to assess for left upper extremity ischemic symp-
toms given the patient’s impaired mental status secondary
to head trauma, expectant management was not employed.
One patient underwent balloon angioplasty of the most
proximal of three Gore Excluder Aortic Extender cuffs on
postprocedure day two due to endograft malapposition to
the lesser curvature of the distal arch. The final patient was
also noted to have malapposition of a Zenith AAA iliac leg
extension to the lesser curve, and a hemodynamically sig-
nificant pressure gradient (61 mm Hg) was measured across
the endoprosthesis. Attempted balloon angioplasty was
partially successful at improving endograft apposition, but
the pressure gradient was unresolved (52 mm Hg). The
e of m
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this resulted in the development heart failure and signs of
poor distal perfusion. Endograft explantation and repair
with an interposition graft was not feasible due to severe
pulmonary contusions and inability to tolerate single-lung
ventilation. This functional coarctation was resolved with
the deployment of a Palmaz P4010 stent (Johnson &
Johnson, Warren, NJ) across the proximal portion of the
endograft improving apposition to the distal arch and re-
solving the pressure gradient. The patient’s symptoms of
distal malperfusion resolved, and she was discharged from
the hospital following recovery from her traumatic injuries.
Two EV patients died within 30 days of intervention
due to multisystem organ failure (MSOF) and withdrawal
of life supporting measures on one patient of advanced age
with multiple associated traumatic injuries. For the open
surgical group, in addition to the 11 intraoperative
deaths, there were eight in-hospital deaths (30 days).
Causes of death included MSOF (n  6), cerebrovascu-
lar accident (n  1), and withdrawal of life supporting
measures (n  1).
DISCUSSION
In this study, EV repair was associated with significant
Table II. Operative data and hospital complications: endo
Value EV
n 14
In-hospital delay (mean)* 10 hrs 50 m
Range 31-2163 m
Injury to intervention (mean)† 72 hrs 56 m
Range 282-19952
Operative Data
Mean operative time (min) 118
Mean estimated blood loss (ml) 77
Mean blood transfusion (units) .9
Intraoperative death 0 (0%)
Complications
n 14
Mean ICU stay (days) 23.6‡
Range 0-4315 h
LOS (days) 34.7
Range 2-249
Multisystem organ failure 1 (7%)
Pneumonia 7 (50%)
Pulmonary embolus 0 (0%)
Tracheostomy 5 (36%)
Renalx 1 (7%)
Cerebrovascular accident 1 (7%)
New neurologic deficits 0 (0%)
Recurrent laryngeal nerve injury 0 (0%)
Urinary tract infection 1 (7%)
Bacteremia 3 (21%)
Deep venous thrombosis 2 (14%)
30-day mortality 2 (14%)
EV, Endovascular, ICU, intensive care unit, LOS, length of stay.
*Time of arrival for patients with known aortic injury or time of diagnosis a
†Time of injury to time of presentation to the operating room.
‡n  12, time of injury and duration in ICU data incomplete on two EV p
§n  44, blood loss not reported on four open surgical patients.
xAcute renal failure or insufficiency (creatinine 1.5 mg/dL) in the absencreductions in operative time, estimated blood loss, andintraoperative blood transfusions despite the utilization of
intraoperative blood salvage in the majority of open surgi-
cal patients. These benefits occurred despite similar patient
characteristics between the EV and open surgical groups.
Neither the initial physiologic injury severity score (RTS),
nor anatomic measures of injury severity (ISS and NISS)
differed significantly. Additionally, the proportion of indi-
vidual associated traumatic injuries were essentially equally
represented between EV and open surgical groups, as was
the proportion of patients who demonstrated hemody-
namic instability prior to intervention. These observations
would suggest that the EV and open surgical groups were
comparable in terms of injury severity. Despite these mea-
sures of injury severity, the majority of the EV patients had
been assessed by cardiothoracic surgeons to be prohibitive
operative candidates. The intraoperative dearth rate was
lower for the EV group (0% vs 23%). The failure to reach
the traditional statistical cut-off of P .05 for this compar-
ison appears to be a type II error due to the small sample
size in the EV group.
Pulmonary complications are common following open
repair18,19 and may possibly be contributed to by the need
to perform a thoracotomy. Despite this, we did not observe
a significant reduction in pulmonary complications with EV
ular and open repair
Open P
48
10 hrs 6 min .940
14-14204 min
23 hrs 15 min .035
121-16054 min
209 .001
3180§ .005
6.1 .001
11 (23%) .056
37
18.9 .631
17-1825 hrs
28.1 .551
1-97
6 (16%) .657
26 (70%) .204
2 (5%) 1.000
14 (38%) 1.000
12 (32%) .082
1 (3%) .478
0 (0%) 1.000
3 (8%) .552
13(35%) .077
10 (27%) 1.000
4 (11%) .661
19 (40%) .111
institution, to time of presentation to the operating room.
.
ultisystem organ failure.vasc
in
in
in‡
min
rs
t our
atientstherapy. Injuries to the lung and chest wall are commonly
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associated traumatic injuries in both the EV and open
surgical groups. The severity of associated pulmonary inju-
ries may preclude the patient from undergoing an emergent
open surgical repair due to the inability to tolerate single-
lung ventilation. Variation in the severity of these injuries
may account for this lack of observed benefit to EV repair
and more quantitative measurements of pulmonary com-
plications may demonstrate advantages in future studies.
Although infectious complications might be expected to be
higher in the open surgical group given the immunosup-
pressive effects of thoracotomy20 and multiple blood trans-
fusions,21 the incidence of pneumonia and bacteremia were
not significantly different compared to the EV group.
Paraplegia is a devastating complication associated with
open surgical repair of TAI.4,22 Although the use of partial
bypass has reduced the incidence of paraplegia, this com-
plication still occurs.5,23 Of the open surgical operative
survivors in our series, 97% underwent partial bypass, and
there were no postoperative cases of paraplegia. This ben-
efit of distal perfusion occurred despite a mean aortic
cross-clamp time 30 minutes, which has been associated
with the development of paraplegia even in the setting of
distal perfusion.4,17 Although paraplegia has been observed
after elective EV repair of degenerative thoracic aneu-
rysms,7 there has never been a reported case of this compli-
cation following EV repair of blunt TAI.24
Two endograft specific complications were observed.
Two patients experienced malapposition to the lesser cur-
vature of the distal arch; one had received multiple Gore
Excluder Aortic Extender cuffs, and the other received a
Zenith AAA iliac leg extender. Complications such as de-
vice collapse following thoracic endograft repair of blunt
TAI have been previously reported.25,26 Malapposition of
endografts to the inferior curve of the distal aortic arch is a
potential consequence of the application of currently avail-
able endografts to the relatively young healthy aortas en-
countered in the trauma patient population. Malapposition
may lead to device collapse or a functional coarctation. One
of the EV patients required deployment of a Palmaz stent
across the proximal portion of the endograft in order to
improve apposition. Successful utilization of balloon ex-
pandable stents or additional endograft components to
improve proximal apposition and resolve endograft collapse
has previously been reported,25,27
Experience with endografts to treat blunt TAI is limited
and difficult to study given the low prevalence of patients
who survive to presentation. Retrospective case series of
acute EV repair of TAI report an intraoperative mortality of
0%, and a hospital mortality of 6.3% to 14.3%10,11,28,29
consistent with the outcomes observed in our series. A
current search of the English literature revealed nine single-
institution studies that report parallel outcomes for both
open surgical and EV treatment of acute TAI (Table
III).9,30-37 Review of these reported outcomes reveals an
absence of intraoperative mortality and postoperative para-
plegia/paraparesis events, as well as a tendency for less
hospital mortality in patients who underwent EV repair. Weconsidered subjecting these reports to a meta-analysis al-
though the small number of subjects in each study, variabil-
ity in open surgical techniques, and inclusion of patients
treated greater then 14 days from the time of injury made
statistical conclusions unreliable. Additionally, these re-
ports are limited by their retrospective case control design,
as well as possible reporting biases for outcomes in favor of
EV therapy.
Candidacy and endograft availability are important
considerations when considering EV repair of a TAI. Ap-
proximately 90% to 93% of patients who survive to presen-
tation sustain injuries to the aortic isthmus or distal thoracic
aorta,4,17,18 and therefore may be EV candidates without
the need for extra-anatomic bypass. Obtaining an adequate
proximal landing zone may require coverage of the left
SCA,38 although this appears to be well tolerated without
revascularization given no contraindications.39 The diam-
eter of the vessel lumen currently dictates device selection.
The smallest Gore TAG endoprosthesis available (26 mm)
allows for the treatment of patients with landing zone
diameters as small as 23 mm based in the manufacturer’s
IFU. Current device lengths allow for adequate coverage of
these lesions without the need for multiple components.
Based upon indirect measures of aortic vessel diameter, 27%
of patients in our series who underwent open repair would
have been candidates for currently available thoracic en-
dografts, while the remaining 73% would require abdomi-
nal aortic endograft components. Off-label utilization of
abdominal aortic endografts in the thoracic territory has
been previously reported8,40 and allows for the treatment
of these smaller aortas.
We have found that main body extension cuffs and
flexible iliac leg extensions are the abdominal aortic en-
dograft components best suited for application to traumatic
aortic injuries in the thoracic territory when the aortic
diameter is less than 23 mm or the radius of curvature is
small. In general, three abdominal aortic cuff components
are required to successfully exclude most injuries. Based
upon device sizing, distal to proximal cuff deployment is
ideal although not always practical. The utilization of mul-
tiple short extension cuffs may allow for improved accom-
modation to the curvature of the distal arch, although this
may put the patient at risk for component separation and
type III endoleak. Iliac leg extenders may allow for repair
with a single endoprosthesis. Stiff iliac components should
be avoided as these devices can resist accommodation to the
curvature of the distal arch resulting in significant malap-
position, as was observed in our one patient who received a
single Zenith AAA iliac leg extension. Additionally, the
diameters of the femoral and iliac vessels, as well as the
maximal length of the delivery system to be utilized, can
dictate the need for a more proximal level of vascular access
necessitating a more invasive procedure.24
Long-term radiographic surveillance is necessary to
monitor the integrity of the endoprosthesis. This may
present a problem for patients who undergo EV repair for
TAIs as the reliability of this patient population to fol-
low-up after discharge may be difficult to assess. Issues
e cens
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decision to perform EV repair.
CONCLUSION
The utilization of thoracic and abdominal aortic en-
dograft components to treat blunt TAI results in reductions
in operative time, blood loss, and intraoperative blood
transfusions compared with open surgical reconstruction.
Furthermore, a review of comparative studies to date sug-
gests that EV repair may be associated with reductions in
intraoperative mortality, hospital mortality, and paraple-
gia/paraparesis. Additional experience with EV repair of
blunt TAIs may clarify these observations. Endograft re-
pairs of blunt TAIs may be prone to device-related compli-
cations and the long-term durability of endografts in this
patient population remains to be defined.
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